These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16119248

  • 1. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig.
    Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG.
    Hum Exp Toxicol; 2005 Jul; 24(7):347-52. PubMed ID: 16119248
    [Abstract] [Full Text] [Related]

  • 2. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H, Hall C, Matar H, Dalton C, Chipman JK, Graham JS, Chilcott RP.
    J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
    [Abstract] [Full Text] [Related]

  • 3. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro.
    Dalton CH, Hattersley IJ, Rutter SJ, Chilcott RP.
    Toxicol In Vitro; 2006 Dec; 20(8):1532-6. PubMed ID: 16904285
    [Abstract] [Full Text] [Related]

  • 4. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine.
    Duncan EJ, Brown A, Lundy P, Sawyer TW, Hamilton M, Hill I, Conley JD.
    J Appl Toxicol; 2002 Dec; 22(3):141-8. PubMed ID: 12015792
    [Abstract] [Full Text] [Related]

  • 5. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig.
    Chilcott RP, Dalton CH, Hill I, Davidson CM, Blohm KL, Hamilton MG.
    Hum Exp Toxicol; 2003 May; 22(5):255-61. PubMed ID: 12774888
    [Abstract] [Full Text] [Related]

  • 6. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations.
    Vallet V, Cruz C, Licausi J, Bazire A, Lallement G, Boudry I.
    Toxicology; 2008 Apr 03; 246(1):73-82. PubMed ID: 18294748
    [Abstract] [Full Text] [Related]

  • 7. Human scalp permeability to the chemical warfare agent VX.
    Rolland P, Bolzinger MA, Cruz C, Briançon S, Josse D.
    Toxicol In Vitro; 2011 Dec 03; 25(8):1974-80. PubMed ID: 21762776
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig.
    Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG.
    Basic Clin Pharmacol Toxicol; 2005 Jul 03; 97(1):35-8. PubMed ID: 15943757
    [Abstract] [Full Text] [Related]

  • 9. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
    Hamilton MG, Hill I, Conley J, Sawyer TW, Caneva DC, Lundy PM.
    Mil Med; 2004 Nov 03; 169(11):856-62. PubMed ID: 15605929
    [Abstract] [Full Text] [Related]

  • 10. Liquid chromatography tandem mass spectrometry applied to quantitation of the organophosphorus nerve agent VX in microdialysates from blood probes.
    Stubbs SJ, Read RW.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May 15; 878(17-18):1253-6. PubMed ID: 20034857
    [Abstract] [Full Text] [Related]

  • 11. Predicted chemical warfare agent VX toxicity to uniformed soldier using parathion in vitro human skin exposure and absorption.
    Wester RM, Tanojo H, Maibach HI, Wester RC.
    Toxicol Appl Pharmacol; 2000 Oct 15; 168(2):149-52. PubMed ID: 11032770
    [Abstract] [Full Text] [Related]

  • 12. Acute pulmonary toxicity following inhalation exposure to aerosolized VX in anesthetized rats.
    Peng X, Perkins MW, Simons J, Witriol AM, Rodriguez AM, Benjamin BM, Devorak J, Sciuto AM.
    Inhal Toxicol; 2014 Jun 15; 26(7):371-9. PubMed ID: 24766293
    [Abstract] [Full Text] [Related]

  • 13. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH, Smith KH, Doxzon BF, Lumpkin HL, Clarkson ED.
    Cutan Ocul Toxicol; 2011 Mar 15; 30(1):15-28. PubMed ID: 20942572
    [Abstract] [Full Text] [Related]

  • 14. An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX.
    Dorandeu F, Foquin A, Briot R, Delacour C, Denis J, Alonso A, Froment MT, Renault F, Lallement G, Masson P.
    Toxicology; 2008 Jun 27; 248(2-3):151-7. PubMed ID: 18450356
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous quantification of VX and its toxic metabolite in blood and plasma samples and its application for in vivo and in vitro toxicological studies.
    Reiter G, Mikler J, Hill I, Weatherby K, Thiermann H, Worek F.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep 15; 879(26):2704-13. PubMed ID: 21862421
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness and reaction networks of H2O2 vapor with NH3 gas for decontamination of the toxic warfare nerve agent, VX on a solid surface.
    Gon Ryu S, Wan Lee H.
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015 Sep 15; 50(14):1417-27. PubMed ID: 26327407
    [Abstract] [Full Text] [Related]

  • 17. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig.
    Mumford H, Price ME, Wetherell JR.
    J Appl Toxicol; 2008 Jul 15; 28(5):694-702. PubMed ID: 18059069
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methodological contributions towards LC-MS/MS quantification of free VX in plasma: An innovative approach.
    Debouit C, Bazire A, Lallement G, Daveloose D.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov 15; 878(30):3059-66. PubMed ID: 20947456
    [Abstract] [Full Text] [Related]

  • 20. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F, Seeger T, Reiter G, Goldsmith M, Ashani Y, Leader H, Sussman JL, Aggarwal N, Thiermann H, Tawfik DS.
    Toxicol Lett; 2014 Nov 18; 231(1):45-54. PubMed ID: 25195526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.